When your genetic information informs your increased risk for a disease and you make lifestyle changes to reduce that risk, personalized medicine has revealed itself. If you have a gene variation that influences how you process a medication and your physician prescribes dosing instructions accordingly, your medical care is now safer, well-timed, accurate, and more cost-effective for you and our healthcare system.
Personalized medicine is the use of genomic information – in addition to family history, lifestyle, and environmental factors – to customize health management. By combining genomic and clinical information, more accurate predictions can be made about a person’s susceptibility of developing disease, the course of disease, and response to treatment.
Personalized medicine is a relatively new field and outcomes research and evidence-based literature is important to its integration into healthcare delivery. The Coriell Personalized Medicine Collaborative® (CPMC®) research study is contributing to both: CPMC study participants regularly complete follow-up questionnaires that explore how they are using the information they receive from the study, whether they are making lifestyle changes to reduce their disease risk or improving their medication response, and if they are sharing their results with family and healthcare providers. Additionally, Coriell has and will continue to publish scientific findings that contribute to medical literature.
A recent update in our nation’s laws is helping to promote the field of personalized medicine: The Genetic Information Non-Discrimination Act of 2008 (GINA) prohibits the use of genetic/genomic information by health insurance companies for determining a person’s eligibility for insurance or insurance premiums — as well as by employers for making decisions about functions such as hiring and firing, assigning jobs, and promoting and demoting.